The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration

Tissue Engineering - Part B: Reviews

Volumn 19, Issue 6, 2013, Pages 516-528

  Chen, Jiezhong ^a,b,c   Crawford, Ross ^a   Chen, Chen ^b   Xiao, Yin ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE PRODUCTION; MESENCHYMAL STEM CELL; MULTIPOTENT CELLS; PHOSPHOINOSITIDE 3-KINASE; PI3K/AKT PATHWAYS; PI3K/AKT SIGNALING; SIGNALING PATHWAYS; TISSUE ENGINEERING APPLICATIONS;

CELL CULTURE; FLOWCHARTING; STEM CELLS; TISSUE; TISSUE REGENERATION;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; CYTOKINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TISSUE SCAFFOLD;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; MESENCHYMAL STROMAL CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REGENERATION; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

EID: 84887877306     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2012.0672     Document Type: Review

References (173)

1. Kuraitis, D., Giordano, C., Ruel, M., Musaro, A., and Suuronen, E.J. Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. Biomaterials 33, 428, 2012
2. Wang, S., Qu, X., and Zhao, R.C. Mesenchymal stem cells hold promise for regenerative medicine. Front Med 5, 372, 2011
3. Jung, Y., Bauer, G., and Nolta, J.A. Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30, 42, 2012
4. Mareddy, S., Dhaliwal, N., Crawford, R., and Xiao, Y. Stem cell-related gene expression in clonal populations of mesenchymal stromal cells from bone marrow. Tissue Eng Part A 16, 749, 2010
5. Prockop, D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71, 1997
6. Sreejit, P., Dilip, K.B., and Verma, R.S. Generation of mesenchymal stem cell lines from murine bone marrow. Cell Tissue Res 350, 55, 2012
7. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002
8. Halfon, S., Abramov, N., Grinblat, B., and Ginis, I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev 20, 53, 2011
9. Xiao, Y., Mareddy, S., and Crawford, R. Clonal characterization of bone marrow derived stem cells and their application for bone regeneration. Int J Oral Sci 2, 127, 2010
10. Bulman, S.E., Barron, V., Coleman, C.M., and Barry, F. Enhancing the mesenchymal stem cell therapeutic response: cell localization and support for cartilage repair. Tissue Eng Part B Rev 19, 58, 2012
11. Szpalski, C., Barbaro, M., Sagebin, F., and Warren, S.M. Bone tissue engineering: current strategies and techniques-part II: cell types. Tissue Eng Part B Rev 18, 258, 2012
12. Szpalski, C., Wetterau, M., Barr, J., and Warren, S.M. Bone tissue engineering: current strategies and techniques-part I: scaffolds. Tissue Eng Part B Rev 18, 246, 2012
13. Colnot, C. Cell sources for bone tissue engineering: insights from basic science. Tissue Eng Part B Rev 17, 449, 2011
14. Janicki, P., and Schmidmaier, G. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury 42 Suppl 2, S77, 2011
15. Kempen, D.H., Creemers, L.B., Alblas, J., Lu, L., Verbout, A.J., Yaszemski, M.J., et al. Growth factor interactions in bone regeneration. Tissue Eng Part B Rev 16, 551, 2010
16. Bilic, J., and Izpisua Belmonte, J.C. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells 30, 33, 2012
17. Sokol, S.Y. Maintaining embryonic stem cell pluripotency with Wnt signaling. Development 138, 4341, 2011
18. Robinton, D.A., and Daley, G.Q. The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295, 2012
19. Wang, X., Chen, T., Leng, L., Fan, J., Cao, K., Duan, Z., et al. MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation. Cancer Res 72, 2867, 2012
20. Shi, Y., Su, J., Roberts, A.I., Shou, P., Rabson, A.B., and Ren, G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33, 136, 2012
21. Weiss, D.J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis- Mortari, A., Reynolds, S., et al. Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 8, 223, 2011
22. Pittenger, M.F., and Martin, B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9, 2004
23. Murphy, J.M., Fink, D.J., Hunziker, E.B., and Barry, F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48, 3464, 2003
24. Iihoshi, S., Honmou, O., Houkin, K., Hashi, K., and Kocsis, J.D. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 1007, 1, 2004
25. Hanabusa, K., Nagaya, N., Iwase, T., Itoh, T., Murakami, S., Shimizu, Y., et al. Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats. Stroke 36, 853, 2005
26. Tang, J., Wang, J., Yang, J., Kong, X., Zheng, F., Guo, L., et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 36, 644, 2009
27. Tian, H., Lu, Y., Shah, S.P., Wang, Q., and Hong, S. 14S,21R-dihydroxy- docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury. Stem Cells Dev 21, 1187, 2012
28. Horwitz, E.M., Prockop, D.J., Fitzpatrick, L.A., Koo, W.W., Gordon, P.L., Neel, M., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5, 309, 1999
29. Wollert, K.C., Meyer, G.P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141, 2004
30. Otsuru, S., Gordon, P.L., Shimono, K., Jethva, R., Marino, R., Phillips, C.L., et al. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 120, 1933, 2012
31. Giordano, A., Galderisi, U., and Marino, I.R. From the laboratory bench to the patient?s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211, 27, 2007
32. Bunnell, B.A., Flaat, M., Gagliardi, C., Patel, B., and Ripoll, C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45, 115, 2008
33. Gang, E.J., Jeong, J.A., Hong, S.H., Hwang, S.H., Kim, S.W., Yang, I.H., et al. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22, 617, 2004
34. Miao, Z., Jin, J., Chen, L., Zhu, J., Huang, W., Zhao, J., et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30, 681, 2006
35. Xiao, Y., and Chen, J. Proteomics approaches in the identification of molecular signatures of mesenchymal stem cells. Adv Biochem Eng Biotechnol 129, 153, 2013
36. Carlotti, F., Zaldumbide, A., Loomans, C.J., van Rossenberg, E., Engelse, M., de Koning, E.J., et al. Isolated human islets contain a distinct population of mesenchymal stem cells. Islets 2, 164, 2010
37. Zhou, Z., Chen, Y., Zhang, H., Min, S., Yu, B., He, B., et al. Comparison of mesenchymal stem cells from human bone marrow and adipose tissue for the treatment of spinal cord injury. Cytotherapy 15, 434, 2013
38. Murry, C.E., Soonpaa, M.H., Reinecke, H., Nakajima, H., Nakajima, H.O., Rubart, M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664, 2004
39. Liu, X., Duan, B., Cheng, Z., Jia, X., Mao, L., Fu, H., et al. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell 2, 845, 2011
40. Hu, X., Yu, S.P., Fraser, J.L., Lu, Z., Ogle, M.E., Wang, J.A., et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135, 799, 2008
41. Ranganath, S.H., Levy, O., Inamdar, M.S., and Karp, J.M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10, 244, 2012
42. Wu, C., Zhang, Y., Ke, X., Xie, Y., Zhu, H., Crawford, R., et al. Bioactive mesopore-glass microspheres with controllable protein-delivery properties by biomimetic surface modification. J Biomed Mater Res A 95, 476, 2010
43. Aamodt, K., Abrahantes Quintana, A., Adamova, D., Adare, A.M., Aggarwal, M.M., Aglieri Rinella, G., et al. Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett 106, 032301, 2011
44. Zhang, Y., Fan, W., Nothdurft, L., Wu, C., Zhou, Y., Crawford, R., et al. In vitro and in vivo evaluation of adenovirus combined silk fibroin scaffolds for BMP-7 gene delivery. Tissue Eng Part C Methods 17, 789, 2011
45. Aamodt, K., Abelev, B., Quintana, A.A., Adamova, D., Adare, A.M., Aggarwal, M.M., et al. Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett 105, 252302, 2010
46. Mao, X., Peng, H., Ling, J., Friis, T., Whittaker, A.K., Crawford, R., et al. Enhanced human bone marrow stromal cell affinity for modified poly(L-lactide) surfaces by the upregulation of adhesion molecular genes. Biomaterials 30, 6903, 2009
47. Tang, J., Zhang, L., She, X., Zhou, G., Yu, F., Xiang, J., et al. Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo. Cancer Invest 30, 380, 2012
48. Geiger, F., Lorenz, H., Xu, W., Szalay, K., Kasten, P., Claes, L., Augat, P., Richter, W. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. Bone 41, 516, 2007
49. Wu, C., Zhou, Y., Fan, W., Han, P., Chang, J., Yuen, J., et al. Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials 33, 2076, 2012
50. Chen, J. Multiple signal pathways in obesity-associated cancer. Obes Rev 12, 1063, 2011
51. Martelli, A.M., Evangelisti, C., Chiarini, F., Grimaldi, C., Cappellini, A., Ognibene, A., et al. The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. Biochim Biophys Acta 1803, 991, 2010
52. Weichhart, T., and Saemann, M.D. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis 67 Suppl 3, iii70, 2008
53. Zhao, T., Qi, Y., Li, Y., and Xu, K. PI3 Kinase regulation of neural regeneration and muscle hypertrophy after spinal cord injury. Mol Biol Rep 39, 3541, 2012
54. Liu, P., Cheng, H., Roberts, T.M., and Zhao, J.J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8, 627, 2009
55. Brunet, A., Datta, S.R., and Greenberg, M.E. Transcriptiondependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11, 297, 2001
56. Cantley, L.C. The phosphoinositide 3-kinase pathway. Science 296, 1655, 2002
57. Hers, I., Vincent, E.E., and Tavare, J.M. Akt signalling in health and disease. Cell Signal 23, 1515, 2011
58. Mangi, A.A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9, 1195, 2003
59. Cho, Y.H., Cha, M.J., Song, B.W., Kim, I.K., Song, H., Chang, W., et al. Enhancement of MSC adhesion and therapeutic efficiency in ischemic heart using lentivirus delivery with periostin. Biomaterials 33, 1376, 2012
60. Lim, S.Y., Kim, Y.S., Ahn, Y., Jeong, M.H., Hong, M.H., Joo, S.Y., et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 70, 530, 2006
61. Morra, L., and Moch, H. Periostin expression and epithelial- mesenchymal transition in cancer: a review and an update. Virchows Arch 459, 465, 2011
62. Ruan, K., Bao, S., and Ouyang, G. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 66, 2219, 2009
63. Li, W., Ma, N., Ong, L.L., Nesselmann, C., Klopsch, C., Ladilov, Y., et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25, 2118, 2007
64. He, F., He, Z., Li, L., Qin, X., Deng, S.M., and Liu, F. Protective effects of bone marrow mesenchymal stem cells with stable expression of Bcl-2 on ischemiahypoxia of hippocampal neurons. Sci Res Essays 6, 2763, 2011
65. Wang, Z.J., Zhang, F.M., Wang, L.S., Yao, Y.W., Zhao, Q., and Gao, X. Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor( TLR)-4 and PI3K/Akt. Cell Biol Int 33, 665, 2009
66. Yin, Q., Jin, P., Liu, X., Wei, H., Lin, X., Chi, C., et al. SDF- 1alpha inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways. Mol Biol Rep 38, 9, 2011
67. Pasha, Z., Wang, Y., Sheikh, R., Zhang, D., Zhao, T., and Ashraf, M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77, 134, 2008
68. Kortesidis, A., Zannettino, A., Isenmann, S., Shi, S., Lapidot, T., and Gronthos, S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105, 3793, 2005
69. Herberg, S., Shi, X., Johnson, M.H., Hamrick, M.W., Isales, C.M., Hill, W.D. Stromal cell-derived factor-1b mediates cell survival through enhancing autophagy in bone marrow- derived mesenchymal stem cells. PLoS One 8, e58207, 2013
70. Jang, M.W., Yun, S.P., Park, J.H., Ryu, J.M., Lee, J.H., and Han, H.J. Cooperation of Epac1/Rap1/Akt and PKA in prostaglandin E(2)-induced proliferation of human umbilical cord blood derived mesenchymal stem cells: involvement of c-Myc and VEGF expression. J Cell Physiol 227, 3756, 2012
71. Zhao, L., and Hantash, B.M. TGF-beta1 regulates differentiation of bone marrow mesenchymal stem cells. Vitam Horm 87, 127, 2011
72. Bocker, W., Docheva, D., Prall, W.C., Egea, V., Pappou, E., Rossmann, O., et al. IKK-2 is required for TNF-alphainduced invasion and proliferation of human mesenchymal stem cells. J Mol Med (Berl) 86, 1183, 2008
73. Kim, J.M., Cho, H.H., Lee, S.Y., Hong, C.P., Yang, J., Kim, Y.S., et al. Role of IRAK1 on TNF-induced proliferation and NF-kB activation in human bone marrow mesenchymal stem cells. Cell Physiol Biochem 30, 49, 2012
74. Auletta, J.J., Zale, E.A., Welter, J.F., and Solchaga, L.A. Fibroblast growth factor-2 enhances expansion of human bone marrow-derived mesenchymal stromal cells without diminishing their immunosuppressive potential. Stem Cells Int 2011, 235176, 2011
75. Choi, S.C., Kim, S.J., Choi, J.H., Park, C.Y., Shim, W.J., and Lim, D.S. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev 17, 725, 2008
76. Tamama, K., Fan, V.H., Griffith, L.G., Blair, H.C., and Wells, A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24, 686, 2006
77. Krampera, M., Pasini, A., Rigo, A., Scupoli, M.T., Tecchio, C., Malpeli, G., et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106, 59, 2005
78. Wu, X., Chen, S., Orlando, S.A., Yuan, J., Kim, E.T., Munugalavadla, V., et al. p85alpha regulates osteoblast differentiation by cross-talking with the MAPK pathway. J Biol Chem 286, 13512, 2011.
79. Ito, H. Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources. Mod Rheumatol 21, 113, 2011
80. Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Jung, S., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175, 2006
81. Kumar, S., and Ponnazhagan, S. Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Bone 50, 1012, 2012
82. Huang, Y.C., and Liu, T.J. Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/tripolyphosphate/fucoidan nanoparticles. Acta Biomater 8, 1048, 2012
83. Pollard, T.D., and Borisy, G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453, 2003
84. Cramer, L.P. Forming the cell rear first: breaking cell symmetry to trigger directed cell migration. Nat Cell Biol 12, 628, 2010
85. Pollard, T.D., and Cooper, J.A. Actin, a central player in cell shape and movement. Science 326, 1208, 2009
86. Ip, C.K., Cheung, A.N., Ngan, H.Y., and Wong, A.S. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 30, 2420, 2011
87. Guo, F., Debidda, M., Yang, L., Williams, D.A., and Zheng, Y. Genetic deletion of Rac1 GTPase reveals its critical role in actin stress fiber formation and focal adhesion complex assembly. J Biol Chem 281, 18652, 2006
88. Enomoto, A., Murakami, H., Asai, N., Morone, N., Watanabe, T., Kawai, K., et al. Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 9, 389, 2005
89. Jiang, P., Enomoto, A., Jijiwa, M., Kato, T., Hasegawa, T., Ishida, M., et al. An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res 68, 1310, 2008
90. Miyake, H., Maeda, K., Asai, N., Shibata, R., Ichimiya, H., Isotani-Sakakibara, M., et al. The actin-binding protein Girdin and its Akt-mediated phosphorylation regulate neointima formation after vascular injury. Circ Res 108, 1170, 2011
91. Kitamura, T., Asai, N., Enomoto, A., Maeda, K., Kato, T., Ishida, M., et al. Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 10, 329, 2008
92. Chim, H., Miller, E., Gliniak, C., and Alsberg, E. Stromalcell- derived factor (SDF) 1-alpha in combination with BMP- 2 and TGF-beta1 induces site-directed cell homing and osteogenic and chondrogenic differentiation for tissue engineering without the requirement for cell seeding. Cell Tissue Res 350, 89, 2012
93. Liu, H., Xue, W., Ge, G., Luo, X., Li, Y., Xiang, H., et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem Biophys Res Commun 401, 509, 2010
94. Rosova, I., Dao, M., Capoccia, B., Link, D., and Nolta, J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26, 2173, 2008
95. Silva, G.V., Litovsky, S., Assad, J.A., Sousa, A.L., Martin, B.J., Vela, D., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111, 150, 2005
96. Chen, J.J., and Zhou, S.H. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J 18, 675, 2011
97. Piao, W., Wang, H., Inoue, M., Hasegawa, M., Hamada, H., and Huang, J. Transplantation of Sendai viral angiopoietin- 1-modified mesenchymal stem cells for ischemic limb disease. Angiogenesis 13, 203, 2010
98. Hung, S.C., Pochampally, R.R., Chen, S.C., Hsu, S.C., and Prockop, D.J. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25, 2363, 2007
99. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 166, 585, 1996
100. Nakagami, H., Maeda, K., Morishita, R., Iguchi, S., Nishikawa, T., Takami, Y., et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 25, 2542, 2005
101. Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678, 2004
102. Mummery, C.L., Davis, R.P., and Krieger, J.E. Challenges in using stem cells for cardiac repair. Sci Transl Med 2, 27ps17, 2010
103. Gnecchi, M., He, H., Noiseux, N., Liang, O.D., Zhang, L., Morello, F., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20, 661, 2006
104. Doorn, J., Moll, G., Le Blanc, K., van Blitterswijk, C., and de Boer, J. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev 18, 101, 2012
105. Olson, S.D., Pollock, K., Kambal, A., Cary, W., Mitchell, G.M., Tempkin, J., et al. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington?s disease. Mol Neurobiol 45, 87, 2012
106. Granero-Molto, F., Myers, T.J., Weis, J.A., Longobardi, L., Li, T., Yan, Y., et al. Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects. Stem Cells 29, 1537, 2011
107. Crisostomo, P.R., Wang, Y., Markel, T.A., Wang, M., Lahm, T., and Meldrum, D.R. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNKdependent mechanism. Am J Physiol Cell Physiol 294, C675, 2008
108. Forte, G., Minieri, M., Cossa, P., Antenucci, D., Sala, M., Gnocchi, V., et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24, 23, 2006
109. Neuss, S., Becher, E., Woltje, M., Tietze, L., and Jahnen- Dechent, W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 22, 405, 2004
110. Duan, H.F., Wu, C.T., Wu, D.L., Lu, Y., Liu, H.J., Ha, X.Q., et al. Treatment of myocardial ischemia with bone marrowderived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther 8, 467, 2003
111. Cai, L., Johnstone, B.H., Cook, T.G., Liang, Z., Traktuev, D., Cornetta, K., et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 25, 3234, 2007
112. Wen, Q., Zhou, L., Zhou, C., Zhou, M., Luo, W., and Ma, L. Change in hepatocyte growth factor concentration promote mesenchymal stem cell-mediated osteogenic regeneration. J Cell Mol Med 16, 1260, 2011
113. D?Ippolito, G., Schiller, P.C., Perez-stable C, Balkan, W., Roos, B.A., and Howard, G.A. Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 31, 269, 2002
114. Yu, W.H., Chen, Z.G., Zhang, J.L., Zhang, L.R., Ke, H., Huang, L.H., et al. Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells. Mol Cell Biochem 310, 11, 2008
115. Shockley, K.R., Lazarenko, O.P., Czernik, P.J., Rosen, C.J., Churchill, G.A., and Lecka-Czernik, B. PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem 106, 232, 2009
116. Kim, W.K., Jung, H., Kim, D.H., Kim, E.Y., Chung, J.W., Cho, Y.S., et al. Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes. J Cell Sci 122, 4160, 2009
117. Higuchi, C., Myoui, A., Hashimoto, N., Kuriyama, K., Yoshioka, K., Yoshikawa, H., et al. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res 17, 1785, 2002
118. Osyczka, A.M., and Leboy, P.S. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146, 3428, 2005
119. Payne, K.A., Meszaros, L.B., Phillippi, J.A., and Huard, J. Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells. Tissue Eng Part A 16, 3647, 2010
120. Wang, Y., Li, J., Lei, L., Jiang, C., An, S., Zhan, Y., et al. Effects of hypoxia on osteogenic differentiation of rat bone marrow mesenchymal stem cells. Mol Cell Biochem 362, 25, 2012
121. Cho, H.H., Shin, K.K., Kim, Y.J., Song, J.S., Kim, J.M., Bae, Y.C., et al. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 223, 168, 2010
122. Sen, B., Guilluy, C., Xie, Z., Case, N., Styner, M., Thomas, J., et al. Mechanically induced focal adhesion assembly amplifies anti-adipogenic pathways in mesenchymal stem cells. Stem Cells 29, 1829, 2011
123. Case, N., Thomas, J., Sen, B., Styner, M., Xie, Z., Galior, K., et al. Mechanical regulation of glycogen synthase kinase 3beta (GSK3beta) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein. J Biol Chem 286, 39450, 2011
124. Fitter, S., Vandyke, K., Gronthos, S., and Zannettino, A. Suppression of PDGF induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion. J Mol Endocrinol 48, 229, 2012
125. Choi, Y.H., Gu, Y.M., Oh, J.W., and Lee, K.Y. Osterix is regulated by Erk1/2 during osteoblast differentiation. Biochem Biophys Res Commun 415, 472, 2011
126. Kim, H.K., Park, K.S., Lee, J.S., Kim, J.H., Park, D.S., Shin, J.W., et al. Salicylideneamino-2-thiophenol enhances osteogenic differentiation through the activation of MAPK pathways in multipotent bone marrow stem cell. J Cell Biochem 113, 1833, 2012
127. Li, J.L., Cui, B., Qi, L., Li, X.Y., Deng, L.F., Ning, G., et al. NMDA enhances stretching-induced differentiation of osteoblasts through the ERK1/2 signaling pathway. Bone 43, 469, 2008
128. Li, X.D., Liu, Z.Y., Chang, B., Liu, D.X., Chen, B., Guo, C., et al. Panax notoginseng saponins promote osteogenic differentiation of bone marrow stromal cells through the ERK and P38 MAPK signaling pathways. Cell Physiol Biochem 28, 367, 2011
129. Lin, F.H., Chang, J.B., and Brigman, B.E. Role of mitogenactivated protein kinase in osteoblast differentiation. J Orthop Res 29, 204, 2011
130. Peng, S., Zhou, G., Luk, K.D., Cheung, K.M., Li, Z., Lam, W.M., et al. Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Cell Physiol Biochem 23, 165, 2009
131. Schindeler, A., and Little, D.G. Ras-MAPK signaling in osteogenic differentiation: friend or foe? J Bone Miner Res 21, 1331, 2006
132. Fierro, F., Illmer, T., Jing, D., Schleyer, E., Ehninger, G., Boxberger, S., et al. Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif 40, 355, 2007
133. Jonsson, S., Hjorth-Hansen, H., Olsson, B., Wadenvik, H., Sundan, A., and Standal, T. Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro. J Bone Miner Metab 30, 119, 2012
134. Fitter, S., Dewar, A.L., Kostakis, P., To, L.B., Hughes, T.P., Roberts, M.M., et al. Long-term imatinib therapy promotes bone formation in CML patients. Blood 111, 2538, 2008
135. Qiu, W., Chen, L., and Kassem, M. Activation of noncanonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells. Biochem Biophys Res Commun 413, 98, 2011
136. Taipaleenmaki, H., Abdallah, B.M., AlDahmash, A., Saamanen, A.M., and Kassem, M. Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations. Exp Cell Res 317, 745, 2011
137. Hamidouche, Z., Fromigue, O., Nuber, U., Vaudin, P., Pages, J.C., Ebert, R., et al. Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells. J Cell Physiol 224, 509, 2010
138. Platt, M.O., Wilder, C.L., Wells, A., Griffith, L.G., and Lauffenburger, D.A. Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells. Stem Cells 27, 2804, 2009
139. Chen, L., Qanie, D., Jafari, A., Taipaleenmaki, H., Jensen, C.H., Saamanen, A.M., et al. Delta-like 1/fetal antigen-1 (Dlk1/FA1) is a novel regulator of chondrogenic cell differentiation via inhibition of the Akt kinase-dependent pathway. J Biol Chem 286, 32140, 2011.
140. Wu, S., Fadoju, D., Rezvani, G., and De Luca, F. Stimulatory effects of insulin-like growth factor-I on growth plate chondrogenesis are mediated by nuclear factor-kappaB p65. J Biol Chem 283, 34037, 2008
141. Bargellini, I., Piaggesi, A., Cicorelli, A., Rizzo, L., Cervelli, R., Iacopi, E., et al. Predictive value of angiographic scores for the integrated management of the ischemic diabetic foot. J Vasc Surg 57, 1204, 2013
142. Stubbs, S.L., Hsiao, S.T., Peshavariya, H.M., Lim, S.Y., Dusting, G.J., and Dilley, R.J. Hypoxic preconditioning enhances survival of human adipose-derived stem cells and conditions endothelial cells in vitro. Stem Cells Dev 21, 1887, 2012
143. Kim, J.H., Park, S.H., Park, S.G., Choi, J.S., Xia, Y., and Sung, J.H. The pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adiposederived stem cells. Stem Cells Dev 20, 1753, 2011
144. Lee, E.Y., Xia, Y., Kim, W.S., Kim, M.H., Kim, T.H., Kim, K.J., et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 17, 540, 2009
145. Song, S.Y., Chung, H.M., and Sung, J.H. The pivotal role of VEGF in adipose-derived-stem-cell-mediated regeneration. Expert Opin Biol Ther 10, 1529, 2010
146. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm- Grove, C.J., Bovenkerk, J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292, 2004
147. Holzwarth, J.M., and Ma, P.X. Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials 32, 9622, 2011
148. Zhang, Z.Y., Teoh, S.H., Hui, J.H., Fisk, N.M., Choolani, M., and Chan, J.K. The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. Biomaterials 33, 2656, 2012
149. Amini, A.R., Laurencin, C.T., Nukavarapu, S.P. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng 40, 363, 2012
150. Salter, E., Goh, B., Hung, B., Hutton, D., Ghone, N., and Grayson, W.L. Bone tissue engineering bioreactors: a role in the clinic? Tissue Eng Part B Rev 18, 62, 2012
151. Lee, J.Y., Choi, Y.S., Lee, S.J., Chung, C.P., and Park, Y.J. Bioactive peptide-modified biomaterials for bone regeneration. Curr Pharm Des 17, 2663, 2011
152. Woo, K.M., Seo, J., Zhang, R., and Ma, P.X. Suppression of apoptosis by enhanced protein adsorption on polymer/ hydroxyapatite composite scaffolds. Biomaterials 28, 2622, 2007
153. Ryu, M.H., Park, J.H., Park, J.E., Chung, J., Lee, C.H., and Park, H.R. Cobalt chloride stimulates phosphoinositide 3-kinase/Akt signaling through the epidermal growth factor receptor in oral squamous cell carcinoma. Biocell 34, 15, 2010
154. Jin, H.O., An, S., Lee, H.C., Woo, S.H., Seo, S.K., Choe, T.B., et al. Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxiainducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway. Cell Signal 19, 1393, 2007
155. Chachami, G., Simos, G., Hatziefthimiou, A., Bonanou, S., Molyvdas, P.A., and Paraskeva, E. Cobalt induces hypoxiainducible factor-1alpha expression in airway smooth muscle cells by a reactive oxygen species- and PI3K-dependent mechanism. Am J Respir Cell Mol Biol 31, 544, 2004
156. Gabriel, M., Nazmi, K., Dahm, M., Zentner, A., Vahl, C.F., and Strand, D. Covalent RGD modification of the inner pore surface of polycaprolactone scaffolds. J Biomater Sci Polym Ed 2011. DOI: 10.1163/092050611X566793 157.
157. Blit, P.H., Shen, Y.H., Ernsting, M.J., Woodhouse, K.A., and Santerre, J.P. Bioactivation of porous polyurethane scaffolds using fluorinated RGD surface modifiers. J Biomed Mater Res A 94, 1226, 2010
158. Qu, Z., Yan, J., Li, B., Zhuang, J., and Huang, Y. Improving bone marrow stromal cell attachment on chitosan/hydroxyapatite scaffolds by an immobilized RGD peptide. Biomed Mater 5, 065001, 2010
159. Reem T, Tsur-Gang, O., and Cohen, S. The effect of immobilized RGD
160. You, M., Peng, G., Li, J., Ma, P., Wang, Z., Shu, W., et al. Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide. Biomaterials 32, 2305, 2011
161. Zhang, H., Lin, C.Y., and Hollister, S.J. The interaction between bone marrow stromal cells and RGD-modified three-dimensional porous polycaprolactone scaffolds. Biomaterials 30, 4063, 2009
162. Hou, J., Wang, J., Cao, L., Qian, X., Xing, W., Lu, J., et al. Segmental bone regeneration using rhBMP-2-loaded collagen/ chitosan microspheres composite scaffold in a rabbit model. Biomed Mater 7, 035002, 2012
163. Liu, H.W., Chen, C.H., Tsai, C.L., Lin, I.H., and Hsiue, G.H. Heterobifunctional poly(ethylene glycol)-tethered bone morphogenetic protein-2-stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. Tissue Eng 13, 1113, 2007
164. Zhang, H., Migneco, F., Lin, C.Y., and Hollister, S.J. Chemically-conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells. Tissue Eng Part A 16, 3441, 2010
165. Duan, B., and Wang, M. Customized Ca-P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor. J R Soc Interface 7 Suppl 5, S615, 2010
166. Jansen, J.A., Vehof, J.W., Ruhe, P.Q., Kroeze-Deutman, H., Kuboki, Y., Takita, H., et al. Growth factor-loaded scaffolds for bone engineering. J Control Release 101, 127, 2005
167. Fujita, N., Matsushita, T., Ishida, K., Sasaki, K., Kubo, S., Matsumoto, T., et al. An analysis of bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein 2 from a biodegradable sponge composed of gelatin and beta-tricalcium phosphate. J Tissue Eng Regen Med 6, 291, 2012
168. Kim, J., Sharma, A., Runge, B., Waters, H., Doll, B., McBride, S., et al. Osteoblast growth and bone-healing response to three-dimensional poly(epsilon-caprolactone fumarate) scaffolds. J Tissue Eng Regen Med 6, 404, 2012
169. Lee, J.W., Kang, K.S., Lee, S.H., Kim, J.Y., Lee, B.K., and Cho, D.W. Bone regeneration using a microstereolithographyproduced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres. Biomaterials 32, 744, 2011
170. Yilgor, P., Yilmaz, G., Onal, M.B., Solmaz, I., Gundogdu, S., Keskil, S., et al. An in vivo study on the effect of scaffold geometry and growth factor release on the healing of bone defects. J Tissue Eng RegenMed 2012. DOI: 10.1002/term.1456
171. Wang, X., Wenk, E., Zhang, X., Meinel, L., Vunjak- Novakovic, G., and Kaplan, D.L. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 134, 81, 2009
172. Chew, S.A., Kretlow, J.D., Spicer, P.P., Edwards, A.W., Baggett, L.S., Tabata, Y., et al. Delivery of plasmid DNA encoding bone morphogenetic protein-2 with a biodegradable branched polycationic polymer in a critical-size rat cranial defect model. Tissue Eng Part A 17, 751, 2011
173. Mukherjee, A., and Rotwein, P. Akt promotes BMP2- mediated osteoblast differentiation and bone development. J Cell Sci 122, 716, 2009.